Intest Res.  2014 Oct;12(4):266-267. 10.5217/ir.2014.12.4.266.

Risk Factors for Delayed Recurrence of Clostridium difficile Infection

Affiliations
  • 1Department of Internal Medicine, Seoul National University Boramae Hospital, Seoul National University College of Medicine, Seoul, Korea. kjwjor@snu.ac.kr

Abstract

No abstract available.


MeSH Terms

Clostridium difficile*
Recurrence*
Risk Factors*

Reference

1. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005; 353:2433–2441. PMID: 16322603.
Article
2. Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg. 2007; 142:624–631. PMID: 17638799.
Article
3. Hassan SA, Othman N, Idris FM, et al. Prevalence of Clostridium difficile toxin in diarhoeal stool samples of patients from a tertiary hospital in North Eastern Penisular Malaysia. Med J Malaysia. 2012; 67:402–405. PMID: 23082450.
4. Kim YS, Han DS, Kim YH, et al. Incidence and clinical features of Clostridium difficile infection in Korea: a nationwide study. Epidemiol Infect. 2013; 141:189–194. PMID: 22717061.
Article
5. Johnson S. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect. 2009; 58:403–410. PMID: 19394704.
Article
6. Pepin J, Alary ME, Valiquette L, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis. 2005; 40:1591–1597. PMID: 15889355.
Article
7. Garey KW, Sethi S, Yadav Y, DuPont HL. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect. 2008; 70:298–304. PMID: 18951661.
8. Kim JW, Lee KL, Jeong JB, et al. Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea. World J Gastroenterol. 2010; 16:3573–3577. PMID: 20653067.
Article
9. Jung KS, Park JJ, Chon YE, et al. Risk factors for treatment failure and recurrence after metronidazole treatment for Clostridium difficile-associated diarrhea. Gut Liver. 2010; 4:332–337. PMID: 20981209.
Article
10. Ryu HS, Kim YS, Seo GS, Lee YM, Choi SC. Risk factors for recurrent Clostridium difficile Infection. Intest Res. 2012; 10:176–182.
Article
11. Doh YS, Kim YS, Jung HJ, et al. Long-term clinical outcome of Clostridium difficile infection in hospitalized patients: a single center study. Intest Res. 2014; 12:299–305.
Article
Full Text Links
  • IR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr